RxDoctor Payments Data

Nicky Turner

Nurse Practitioner · la Junta, CONPI 1770770133

Payments from drug & device makers

$3,886in general payments, 2019–2025

Across 226 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$710
  • Novo Nordisk$482
  • Lilly USA, LLC$402
  • Sumitomo Pharma America, Inc.$290
  • Pfizer$240
  • Axsome Therapeutics, Inc.$238
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$3,886100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,886 in reported general payments places this provider in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

See all nurse practitioner providers in Colorado

Medicare billing

Part B allowed, 2024
$35,391
Medicare patients
191
Services billed
562

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide23$23,186
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$21,103
EliquisApixaban26$16,456
JardianceEmpagliflozin25$14,371
TrulicityDulaglutide12$11,533
OzempicSemaglutide11$10,189
JanuviaSitagliptin Phosphate14$9,602
Pregabalin20$2,532
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,338
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen102$1,991
Albuterol Sulfate HfaAlbuterol Sulfate49$1,649
Levothyroxine Sodium97$841
Omeprazole42$633
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$614
Atorvastatin Calcium93$571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$402$34,71935 claims
GSKTrelegy Ellipta$85$21,10327 claims
PfizerEliquis$240$16,45626 claims
Boehringer IngelheimJardiance$28$14,37125 claims
Novo NordiskOzempic$482$10,18911 claims
MerckJanuvia$22$9,60214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,384 nurse practitioner providers in Colorado.

Other nurse practitioner in la Junta

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →